Is Procalcitonin Biomarker-Guided Antibiotic Therapy a Cost-Effective Approach to Reduce Antibiotic Resistant and Clostridium difficile Infections in Hospitalized Patients?
Lotte Steuten*, Janne Mewes, Isabelle Lepage-Nefkens, Hubertus Vrijhoef
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Is Procalcitonin Biomarker-Guided Antibiotic Therapy a Cost-Effective Approach to Reduce Antibiotic Resistant and Clostridium difficile Infections in Hospitalized Patients?'. Together they form a unique fingerprint.